Back to News
Market Impact: 0.35
West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top Estimates
Source: zacks.com
Corporate EarningsAnalyst EstimatesCompany Fundamentals
West Pharmaceutical Services reported quarterly earnings of $2.66 per share, beating the Zacks Consensus Estimate of $2.18 by $0.48, or about 22%. Earnings were up from $1.96 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment
WST0.65
More News
- West Pharma earnings show it's more than a GLP-1 play. Why we see more upside
- West Reports Third-Quarter 2026 Results
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- Norwegian shares surge 13% on earnings beat, guidance raise